← Back to Search

Video Game Therapy for Motor Skills Disorder

N/A

Recruiting

Led By Elaine Biddiss, PhD

Research Sponsored by Holland Bloorview Kids Rehabilitation Hospital

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Any motor condition that can be addressed by the Bootle Blast system

Aged 6-17 years

Must not have

Uncontrolled epilepsy triggered by video games

Visual and/or hearing limitations affecting BootleBlast play

Timeline

Screening 3 weeks

Treatment Varies

Follow Up last day of baseline phase

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a 3D video game which could help kids with physical disabilities develop motor skills. It will assess home use, feasibility and user experience to inform product, training and resource development.

Who is the study for?

This trial is for young people aged 6-17 with various motor conditions who are interested in improving their motor skills using a video game called Bootle Blast. Participants need intermittent internet access, the ability to engage in video calls, and must be able to communicate in English. They also require caregiver support and should not have uncontrolled epilepsy triggered by video games or any condition that makes physical activity unsafe.

What is being tested?

The study tests the 'real-world' use of Bootle Blast, a mixed reality video game designed to help children develop motor skills at home. Over 14 weeks, participants will play Bootle Blast while researchers assess how easy it is to set up and use independently, identify what helps or hinders its use, and evaluate its perceived value based on user experience.

What are the potential side effects?

Since Bootle Blast is a non-invasive video game used for therapy purposes, side effects may include typical gaming-related issues such as eye strain or minor musculoskeletal discomfort due to repetitive movements during gameplay.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a motor condition that Bootle Blast can help.

Select...

I am between 6 and 17 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have epilepsy that worsens with video games.

Select...

I have vision or hearing issues that affect my ability to play BootleBlast.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1 of baseline phase; 8th week of intervention phase; 3rd week of follow-up phase

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1 of baseline phase; 8th week of intervention phase; 3rd week of follow-up phase

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 of baseline phase; 8th week of intervention phase; 3rd week of follow-up phase for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Canadian Occupational Performance Measure (COPM)

Performance Quality Rating Scale (PQRS)

Secondary study objectives

Access To Therapy Services Questionnaire

Child and Adolescent Factors Inventory (CAFI)

Children & Adolescent Scale of Participation (CASP)

+12 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Baseline Phase (10 or 21 days)Experimental Treatment1 Intervention

In this study, participants will be randomly allocated to a baseline (A) phase that is further divided into two sub-phases, with different durations of either 10 or 21 days. The allocation to different durations of the baseline phase is randomized in order to mitigate threats to internal validity. During the baseline (A) phase, a representative baseline will be established through repeated measurements of the PQRS. Following the baseline phase (A), the 8-week intervention phase (B) is implemented, followed by a second 3-week (A) phase. There is no separate control group in this study, and all participants receive the same intervention during the intervention phase (B).

0 / 4Eligibility criteria met